Gagnon-Sanschagrin P - Search Results

1

Health Care Resource Utilization and Costs in Patients with Chronic Myeloid Leukemia with Better Adherence to Tyrosine Kinase Inhibitors and Increased Molecular Monitoring Frequency.

Latremouille-Viau D, Guerin A, Gagnon-Sanschagrin P, Dea K, Cohen BG, Joseph GJ. Latremouille-Viau D, et al. J Manag Care Spec Pharm. 2017 Feb;23(2):214-224. doi: 10.18553/jmcp.2017.23.2.214. J Manag Care Spec Pharm. 2017. PMID: 28125373 Free PMC article.

2

Treatment patterns, healthcare resource utilization, and costs in patients with acute myeloid leukemia in commercially insured and Medicare populations.

Stein EM, Bonifacio G, Latremouille-Viau D, Guerin A, Shi S, Gagnon-Sanschagrin P, Briggs O, Joseph GJ. Stein EM, et al. J Med Econ. 2018 Jun;21(6):556-563. doi: 10.1080/13696998.2018.1425209. Epub 2018 Jan 22. J Med Econ. 2018. PMID: 29304724 Free article.

3

Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis.

Kimball AB, Sundaram M, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guérin A, Ganguli A. Kimball AB, et al. J Drugs Dermatol. 2018 Feb 1;17(2):180-186. J Drugs Dermatol. 2018. PMID: 29462226

4

Economic Burden of HR+/HER2- Metastatic Breast Cancer Among Adult Premenopausal Women.

Gauthier G, Gagnon-Sanschagrin P, Guérin A, Burne R, Small T, Niravath P, Dalal AA. Gauthier G, et al. Adv Ther. 2018 Apr;35(4):503-514. doi: 10.1007/s12325-018-0689-x. Epub 2018 Mar 20. Adv Ther. 2018. PMID: 29556908

5

Assessment of costs associated with adverse events in patients with cancer.

Wong W, Yim YM, Kim A, Cloutier M, Gauthier-Loiselle M, Gagnon-Sanschagrin P, Guerin A. Wong W, et al. PLoS One. 2018 Apr 13;13(4):e0196007. doi: 10.1371/journal.pone.0196007. eCollection 2018. PLoS One. 2018. PMID: 29652926 Free PMC article.

6

Dosing Patterns and Economic Burden of Palbociclib Drug Wastage in HR+/HER2- Metastatic Breast Cancer.

Dalal AA, Gagnon-Sanschagrin P, Burne R, Guérin A, Gauthier G, Small T, Niravath P. Dalal AA, et al. Adv Ther. 2018 Jun;35(6):768-778. doi: 10.1007/s12325-018-0701-5. Epub 2018 Jun 4. Adv Ther. 2018. PMID: 29869106

7

Monitoring of Hematologic, Cardiac, and Hepatic Function in Post-Menopausal Women with HR+/HER2- Metastatic Breast Cancer.

Guérin A, Goldschmidt D, Small T, Gagnon-Sanschagrin P, Romdhani H, Gauthier G, Kelkar S, Wu EQ, Niravath P, Dalal AA. Guérin A, et al. Adv Ther. 2018 Aug;35(8):1251-1264. doi: 10.1007/s12325-018-0740-y. Epub 2018 Jun 26. Adv Ther. 2018. PMID: 29946797

8

Treatment and Monitoring Patterns Among Premenopausal Women with HR+/HER2- Advanced Breast Cancer.

Dalal AA, Gauthier G, Gagnon-Sanschagrin P, Burne R, Guérin A, Niravath P, Small T. Dalal AA, et al. Adv Ther. 2018 Sep;35(9):1356-1367. doi: 10.1007/s12325-018-0764-3. Epub 2018 Aug 13. Adv Ther. 2018. PMID: 30105655

9

Burden of Infections Among Chronic Myeloid Leukemia Patients Receiving Dasatinib or Nilotinib: A Real-World Retrospective Healthcare Claims Study in the United States.

Seiter K, Latremouille-Viau D, Guerin A, Ndife B, Habucky K, Tang DH, Pivneva I, Gagnon-Sanschagrin P, Joseph GJ. Seiter K, et al. Adv Ther. 2018 Oct;35(10):1671-1685. doi: 10.1007/s12325-018-0772-3. Epub 2018 Aug 28. Adv Ther. 2018. PMID: 30155792

10

A real-world analysis of healthcare costs and relative risk of hyperprolactinemia associated with antipsychotic treatments in the United States.

Cloutier M, Greene M, Touya M, Gagnon-Sanschagrin P, Guerin A. Cloutier M, et al. J Med Econ. 2018 Dec;21(12):1183-1190. doi: 10.1080/13696998.2018.1521415. Epub 2018 Sep 26. J Med Econ. 2018. PMID: 30188234 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters